What factors are contributing to the recent spike in quality control failures for Metabolon's targeted assays?

Introduction

The recent spike in quality control failures for Metabolon's targeted assays is a critical issue that demands immediate attention and a thorough root cause analysis. As we delve into this problem, we'll employ a systematic approach to identify, validate, and address the underlying factors contributing to these failures. Our goal is not only to resolve the immediate issue but also to implement long-term solutions that prevent future occurrences and strengthen our overall quality control processes.

Step 1

Clarifying Questions (3 minutes)

• Looking at the timing, I'm thinking there might be a recent change in our assay process. Has there been any modification to our standard operating procedures or equipment in the past month?

Why it matters: Recent changes could directly impact quality control. Expected answer: Yes, there was a minor update to the sample preparation protocol. Impact on approach: If confirmed, we'd focus on validating the new protocol's effectiveness.

• Considering the specificity of the issue, I'm wondering if this spike is uniform across all targeted assays or specific to certain types. Can you provide a breakdown of failure rates by assay type?

Why it matters: This helps isolate whether the issue is systemic or specific to certain assays. Expected answer: The spike is more pronounced in lipid-targeted assays. Impact on approach: We'd prioritize investigating factors unique to lipid assays.

• Given the nature of our work, I'm curious about any changes in our sample sources. Have we recently onboarded new sample providers or seen changes in sample demographics?

Why it matters: Sample quality and consistency are crucial for accurate assays. Expected answer: We've expanded our sample sources to include two new providers. Impact on approach: We'd investigate the quality control processes of these new providers.

• Thinking about our quality control metrics, I'm wondering if our definition or measurement of "failure" has changed. Can you confirm if there have been any updates to our QC criteria or measurement systems?

Why it matters: Changes in how we define or measure failures could explain the spike. Expected answer: No changes to QC criteria, but we've upgraded our measurement software. Impact on approach: We'd examine the new software's calibration and data processing methods.